aminoimidazole carboxamide has been researched along with Allodynia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, XJ; Chen, X; Qian, HY; Sun, YZ; Wu, R; Xu, GY; Zhang, PA; Zhu, HY | 1 |
| Geisslinger, G; Martin, LM; Möller, M; Niederberger, E; Pierre, S; Russe, OQ; Scholich, K; Weiss, U | 1 |
| Geisslinger, G; King, TS; Kynast, KL; Möser, CV; Niederberger, E; Russe, OQ; Stephan, H | 1 |
3 other study(ies) available for aminoimidazole carboxamide and Allodynia
| Article | Year |
|---|---|
Metformin attenuates diabetic neuropathic pain via AMPK/NF-κB signaling pathway in dorsal root ganglion of diabetic rats.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Ganglia, Spinal; Hyperalgesia; Hypoglycemic Agents; Male; MAP Kinase Signaling System; Metformin; Neuralgia; NF-kappa B; Rats; Rats, Sprague-Dawley; Ribonucleotides | 2021 |
5-Amino-1-β-D-Ribofuranosyl-Imidazole-4-Carboxamide (AICAR) Reduces Peripheral Inflammation by Macrophage Phenotype Shift.
Topics: Aminoimidazole Carboxamide; Animals; Anti-Inflammatory Agents; Cells, Cultured; Edema; Hyperalgesia; Inflammation; Macrophages; Male; Mice, Inbred C57BL; Ribonucleotides | 2019 |
Activation of the AMP-activated protein kinase reduces inflammatory nociception.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Behavior, Animal; Enzyme Activation; Hyperalgesia; Inflammation; Male; Metformin; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Skills; Nociception; Pain Measurement; Ribonucleotides; Rotarod Performance Test | 2013 |